The Stroke Riskometer™ App: Validation of a Data Collection Tool and Stroke Risk Predictor

Priya Parmar(Auckland University of Technology), Rita Krishnamurthi(Auckland University of Technology), M. Arfan Ikram(Erasmus MC), Albert Hofman(Erasmus MC), Saira Saeed Mirza(Erasmus MC), Yury Varakin(Research Center of Neurology), Michael Kravchenko(Research Center of Neurology), М. А. Пирадов(Research Center of Neurology), Amanda G. Thrift(Monash University), Bo Norrving(Lund University), Wenzhi Wang(Beijing Institute of Neurosurgery), Dipes Kumar Mandal(Liver Foundation West Bengal), Suzanne Barker‐Collo(University of Auckland), Ramesh Sahathevan(University Kebangsaan Malaysia Medical Centre), Stephen M. Davis(The University of Melbourne), Gustavo Saposnik(University of Toronto), Miia Kivipelto(Karolinska Institutet), Shireen Sindi(Karolinska Institutet), Natan M. Bornstein(Tel Aviv University), Maurice Giroud(CHU Dijon Bourgogne), Yannick Béjot(Université de Bourgogne), Michael Brainin(Universität für Weiterbildung Krems), Richie Poulton(University of Otago), K M Venkat Narayan(Emory University), Manuel Correia(Hospital de Santo António), Antônio Fernando Menezes Freire, Yoshihiro Kokubo(National Cerebral and Cardiovascular Center), David O. Wiebers(WinnMed), George A. Mensah(National Institutes of Health), Nasser F. BinDhim(The University of Sydney), P. Alan Barber(University of Auckland), Jeyaraj Pandian(Christian Medical College, Vellore), Graeme J. Hankey(The University of Western Australia), Man Mohan Mehndiratta(BLK Super Speciality Hospital), Shobhana Azhagammal(Liver Foundation West Bengal), Norlinah Mohd Ibrahim(University Kebangsaan Malaysia Medical Centre), Max Abbott(Auckland University of Technology), Elaine Rush(Auckland University of Technology), Patria Hume(Auckland University of Technology), Tasleem Hussein(Auckland University of Technology), Rohit Bhattacharjee(Auckland University of Technology), Mitali Purohit(Auckland University of Technology), Valery L. Feigin(Auckland University of Technology)
International Journal of Stroke
December 10, 2014
Cited by 137Open Access
Full Text

Abstract

BACKGROUND: The greatest potential to reduce the burden of stroke is by primary prevention of first-ever stroke, which constitutes three quarters of all stroke. In addition to population-wide prevention strategies (the 'mass' approach), the 'high risk' approach aims to identify individuals at risk of stroke and to modify their risk factors, and risk, accordingly. Current methods of assessing and modifying stroke risk are difficult to access and implement by the general population, amongst whom most future strokes will arise. To help reduce the burden of stroke on individuals and the population a new app, the Stroke Riskometer(TM) , has been developed. We aim to explore the validity of the app for predicting the risk of stroke compared with current best methods. METHODS: 752 stroke outcomes from a sample of 9501 individuals across three countries (New Zealand, Russia and the Netherlands) were utilized to investigate the performance of a novel stroke risk prediction tool algorithm (Stroke Riskometer(TM) ) compared with two established stroke risk score prediction algorithms (Framingham Stroke Risk Score [FSRS] and QStroke). We calculated the receiver operating characteristics (ROC) curves and area under the ROC curve (AUROC) with 95% confidence intervals, Harrels C-statistic and D-statistics for measure of discrimination, R(2) statistics to indicate level of variability accounted for by each prediction algorithm, the Hosmer-Lemeshow statistic for calibration, and the sensitivity and specificity of each algorithm. RESULTS: The Stroke Riskometer(TM) performed well against the FSRS five-year AUROC for both males (FSRS = 75.0% (95% CI 72.3%-77.6%), Stroke Riskometer(TM) = 74.0(95% CI 71.3%-76.7%) and females [FSRS = 70.3% (95% CI 67.9%-72.8%, Stroke Riskometer(TM) = 71.5% (95% CI 69.0%-73.9%)], and better than QStroke [males - 59.7% (95% CI 57.3%-62.0%) and comparable to females = 71.1% (95% CI 69.0%-73.1%)]. Discriminative ability of all algorithms was low (C-statistic ranging from 0.51-0.56, D-statistic ranging from 0.01-0.12). Hosmer-Lemeshow illustrated that all of the predicted risk scores were not well calibrated with the observed event data (P < 0.006). CONCLUSIONS: The Stroke Riskometer(TM) is comparable in performance for stroke prediction with FSRS and QStroke. All three algorithms performed equally poorly in predicting stroke events. The Stroke Riskometer(TM) will be continually developed and validated to address the need to improve the current stroke risk scoring systems to more accurately predict stroke, particularly by identifying robust ethnic/race ethnicity group and country specific risk factors.


Related Papers

No related papers found

Powered by citation graph analysis